These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16683045)

  • 1. Animal models for the study of Chlamydia trachomatis infections in the female genital infection.
    Vanrompay D; Lyons JM; Morré SA
    Drugs Today (Barc); 2006 Mar; 42 Suppl A():55-63. PubMed ID: 16683045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of untreated chlamydial genital infection and factors associated with clearance: review of animal studies.
    Miyairi I; Ramsey KH; Patton DL
    J Infect Dis; 2010 Jun; 201 Suppl 2():S96-103. PubMed ID: 20470047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description of the ICTI consortium: an integrated approach to the study of Chlamydia trachomatis infection.
    Morré SA; Spaargaren J; Ossewaarde JM; Land JA; Bax CJ; Dörr PJ; Oostvogel PM; Vanrompay D; Savelkoul PH; Pannekoek Y; van Bergen JE; Fennema HS; de Vries HJ; Crusius JB; Peña AS; Ito JI; Lyons JM
    Drugs Today (Barc); 2006 Mar; 42 Suppl A():107-14. PubMed ID: 16683050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific-pathogen-free pigs as an animal model for studying Chlamydia trachomatis genital infection.
    Vanrompay D; Hoang TQ; De Vos L; Verminnen K; Harkinezhad T; Chiers K; Morré SA; Cox E
    Infect Immun; 2005 Dec; 73(12):8317-21. PubMed ID: 16299329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies.
    Geisler WM
    J Infect Dis; 2010 Jun; 201 Suppl 2():S104-13. PubMed ID: 20470048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel guinea pig model of Chlamydia trachomatis genital tract infection.
    de Jonge MI; Keizer SA; El Moussaoui HM; van Dorsten L; Azzawi R; van Zuilekom HI; Peters PP; van Opzeeland FJ; van Dijk L; Nieuwland R; Roosenboom-Theunissen HW; Vrijenhoek MP; Debyser I; Verweij PJ; van Duijnhoven WG; van den Bosch JF; Nuijten PJ
    Vaccine; 2011 Aug; 29(35):5994-6001. PubMed ID: 21718744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia trachomatis serovar E isolates from patients with different clinical manifestations have similar courses of infection in a murine model: host factors as major determinants of C trachomatis mediated pathogenesis.
    Lyons JM; Ito JI; Morré SA
    J Clin Pathol; 2004 Jun; 57(6):657-9. PubMed ID: 15166277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silent upper genital tract chlamydial infection and disease in women.
    Tait IA; Duthie SJ; Taylor-Robinson D
    Int J STD AIDS; 1997 May; 8(5):329-31. PubMed ID: 9175656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated approach to the study of Chlamydia trachomatis infection of the female genital tract.
    Lyons JM
    Drugs Today (Barc); 2006 Mar; 42 Suppl A():83-97. PubMed ID: 16683048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of fallopian tube damage caused by Chlamydia trachomatis infections.
    Hafner LM
    Contraception; 2015 Aug; 92(2):108-15. PubMed ID: 25592078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for Chlamydia infections of the female genital tract.
    Hafner LM; McNeilly C
    Future Microbiol; 2008 Feb; 3(1):67-77. PubMed ID: 18230035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia trachomatis: female pelvic infection.
    Faro S
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 2):1767-70. PubMed ID: 2039030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an immune modulator in experimental Chlamydia trachomatis infection of the female genital tract.
    Lyons JM; Ito JI; Morré SA
    Infect Dis Obstet Gynecol; 2006; 2006():61265. PubMed ID: 17093354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations of genital infection due to Chlamydia trachomatis in women: differences related to serovar.
    Workowski KA; Stevens CE; Suchland RJ; Holmes KK; Eschenbach DA; Pettinger MB; Stamm WE
    Clin Infect Dis; 1994 Oct; 19(4):756-60. PubMed ID: 7803644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.
    Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
    J Microbiol Immunol Infect; 2005 Dec; 38(6):383-93. PubMed ID: 16341338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of vaginally applied imiquimod on the course of Chlamydia trachomatis serovar D infection in a murine model.
    Lyons JM; Ito JI; Morré SA
    Infect Dis Obstet Gynecol; 2005 Mar; 13(1):1-3. PubMed ID: 16040320
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogenesis and immunology of chlamydial infections of the genital tract.
    Johnson AP
    Rev Infect Dis; 1985; 7(6):741-5. PubMed ID: 4070907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of evidence of a relationship between genital symptoms, cervicitis and salpingitis and different serovars of Chlamydia trachomatis.
    Persson K; Osser S
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):195-9. PubMed ID: 8508818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel markers for uncomplicated lower genital tract infections and upper genital tract pathology due to Chlamydia trachomatis.
    Collet T; Macnaughton T; Walsh T; Debattista J; Timms P
    Int J Infect Dis; 2011 Apr; 15(4):e257-66. PubMed ID: 21295509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection.
    Ito JI; Lyons JM; Airo-Brown LP
    Infect Immun; 1990 Jun; 58(6):2021-3. PubMed ID: 2341189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.